(Total Views: 123)
Posted On: 09/09/2020 11:55:49 AM
Post# of 27133
$CLRB News Article - Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients https://marketwirenews.com/news-releases/cell...87221.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
